Monthly Archives: October 2014

OSPHOS

Has your horse been diagnosed with Navicular Syndrome with evidence of radiographic changes? Dechra has received FDA approval to produce and distribute a new bisphosphonate drug that in clinical trials has resulted in at least a 1 grade improvement in lameness in 75% of cases. Osphos which is very similar to Tildren works by inhibiting...
Read More